欧盟批准-话题@MedSci

#欧盟批准#

135篇内容 | 1294人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1589929, encodeId=a2ed15899292b, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=Actelion肺动脉高压药物Opsumit获欧盟批准, objectType=article, longId=28527, objectId=5feb2852ebd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5feb2852ebd, replyNumber=0, likeNumber=29, createdTime=2013-12-26, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5feb2852ebd, moduleTitle=Actelion肺动脉高压药物Opsumit获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5feb2852ebd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589927, encodeId=3e17158992edf, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=强生糖尿病新药INVOKANA获欧盟批准, objectType=article, longId=27074, objectId=00f42e07433, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f42e07433, replyNumber=0, likeNumber=26, createdTime=2013-11-27, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f42e07433, moduleTitle=强生糖尿病新药INVOKANA获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00f42e07433)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589928, encodeId=6c35158992869, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=大冢和灵北精神分裂症药物Abilify Maintena获欧盟批准, objectType=article, longId=27076, objectId=4a812e076e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a812e076e4, replyNumber=0, likeNumber=37, createdTime=2013-11-27, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a812e076e4, moduleTitle=大冢和灵北精神分裂症药物Abilify Maintena获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a812e076e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589924, encodeId=daaa15899249a, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=拜耳抗癌药Xofigo获欧盟批准, objectType=article, longId=26817, objectId=90a82681e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a82681e63, replyNumber=0, likeNumber=27, createdTime=2013-11-22, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a82681e63, moduleTitle=拜耳抗癌药Xofigo获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a82681e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589925, encodeId=714d158992513, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=吉利德HIV药物Vitekta获欧盟批准, objectType=article, longId=26821, objectId=5bed26821d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bed26821d5, replyNumber=0, likeNumber=30, createdTime=2013-11-22, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bed26821d5, moduleTitle=吉利德HIV药物Vitekta获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bed26821d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589926, encodeId=127e1589926fa, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=GSK新复方药Relvar Ellipta获欧盟批准, objectType=article, longId=26822, objectId=fc3226822e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3226822e7, replyNumber=0, likeNumber=26, createdTime=2013-11-22, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3226822e7, moduleTitle=GSK新复方药Relvar Ellipta获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc3226822e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589923, encodeId=d9a015899235c, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准, objectType=article, longId=25213, objectId=d462252130c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d462252130c, replyNumber=0, likeNumber=35, createdTime=2013-10-10, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d462252130c, moduleTitle=勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d462252130c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589922, encodeId=595e158992211, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=吉利德HIV疗法增强剂Tybost获欧盟批准, objectType=article, longId=25165, objectId=9b2b2516593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b2b2516593, replyNumber=0, likeNumber=28, createdTime=2013-10-02, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b2b2516593, moduleTitle=吉利德HIV疗法增强剂Tybost获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b2b2516593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589921, encodeId=2a901589921c0, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=葛兰素史克Revolade新适应症获欧盟批准, objectType=article, longId=25020, objectId=cd2925020ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd2925020ce, replyNumber=0, likeNumber=24, createdTime=2013-09-28, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd2925020ce, moduleTitle=葛兰素史克Revolade新适应症获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd2925020ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589920, encodeId=c45f1589920df, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=拜耳Eylea新适应症获欧盟批准, objectType=article, longId=23541, objectId=af4d2354129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4d2354129, replyNumber=0, likeNumber=27, createdTime=2013-09-01, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4d2354129, moduleTitle=拜耳Eylea新适应症获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4d2354129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589919, encodeId=ea73158991911, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=葛兰素史克Tyberb新适应症获欧盟批准, objectType=article, longId=23132, objectId=a7b72313238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b72313238, replyNumber=0, likeNumber=36, createdTime=2013-08-21, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b72313238, moduleTitle=葛兰素史克Tyberb新适应症获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b72313238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589918, encodeId=d267158991826, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=欧盟批准利伐沙班用于急性冠状动脉综合征的二级预防, objectType=article, longId=19284, objectId=6aab192840c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aab192840c, replyNumber=0, likeNumber=37, createdTime=2013-05-29, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aab192840c, moduleTitle=欧盟批准利伐沙班用于急性冠状动脉综合征的二级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aab192840c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589917, encodeId=8c49158991e1e, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=雅培阿达木单抗（Humira）获欧盟批准用于放射学阴性中轴脊柱关节炎（nr-axSpA）, objectType=article, longId=8486, objectId=da748486dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da748486dd, replyNumber=0, likeNumber=27, createdTime=2012-08-04, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da748486dd, moduleTitle=雅培阿达木单抗（Humira）获欧盟批准用于放射学阴性中轴脊柱关节炎（nr-axSpA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da748486dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589916, encodeId=709615899161f, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=欧盟批准新型糖尿病复合药物, objectType=article, longId=8391, objectId=49c2839163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49c2839163, replyNumber=0, likeNumber=42, createdTime=2012-08-02, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49c2839163, moduleTitle=欧盟批准新型糖尿病复合药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49c2839163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589915, encodeId=8e0d158991586, content=<a href='/topic/show?id=2d1c63118e9' target=_blank style='color:#2F92EE;'>#欧盟批准#</a>, objectTitle=黑色素瘤新药Zelboraf获欧盟批准, objectType=article, longId=4149, objectId=07a84149f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07a84149f2, replyNumber=0, likeNumber=32, createdTime=2012-02-28, rootId=0, userName=chenwq14, userId=f0d617780998, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07a84149f2, moduleTitle=黑色素瘤新药Zelboraf获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07a84149f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

欧盟批准

2020-05-29

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

Actelion肺动脉高压药物Opsumit获欧盟批准

2013-12-26

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

强生糖尿病新药INVOKANA获欧盟批准

2013-11-27

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

大冢和灵北精神分裂症药物Abilify Maintena获欧盟批准

2013-11-27

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

拜耳抗癌药Xofigo获欧盟批准

2013-11-22

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

吉利德HIV药物Vitekta获欧盟批准

2013-11-22

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

GSK新复方药Relvar Ellipta获欧盟批准

2013-11-22

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

勃林格殷格翰抗癌药Giotrif（afatinib）获欧盟批准

2013-10-10

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

吉利德HIV疗法增强剂Tybost获欧盟批准

2013-10-02

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

葛兰素史克Revolade新适应症获欧盟批准

2013-09-28

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

拜耳Eylea新适应症获欧盟批准

2013-09-01

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

葛兰素史克Tyberb新适应症获欧盟批准

2013-08-21

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

欧盟批准利伐沙班用于急性冠状动脉综合征的二级预防

2013-05-29

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

雅培阿达木单抗（Humira）获欧盟批准用于放射学阴性中轴脊柱关节炎（nr-axSpA）

2012-08-04

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

欧盟批准新型糖尿病复合药物

2012-08-02

chenwq14 (审核中...)

前往app查看评论内容

#欧盟批准#

黑色素瘤新药Zelboraf获欧盟批准

2012-02-28

科室
- - 订阅+
  - 更多科室
工具
服务